Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Age-adjusted association of homologous recombination genes with ovarian cancer using clinical exomes as controls.

Arvai KJ, Roberts ME, Torene RI, Susswein LR, Marshall ML, Zhang Z, Carter NJ, Yackowski L, Rinella ES, Klein RT, Hruska KS, Retterer K.

Hered Cancer Clin Pract. 2019 Jul 15;17:19. doi: 10.1186/s13053-019-0119-3. eCollection 2019.

2.

Open Humans: A platform for participant-centered research and personal data exploration.

Greshake Tzovaras B, Angrist M, Arvai K, Dulaney M, Estrada-Galiñanes V, Gunderson B, Head T, Lewis D, Nov O, Shaer O, Tzovara A, Bobe J, Price Ball M.

Gigascience. 2019 Jun 1;8(6). pii: giz076. doi: 10.1093/gigascience/giz076.

3.

Long-term selective estrogen receptor-beta agonist treatment modulates gene expression in bone and bone marrow of ovariectomized rats.

Balla B, Sárvári M, Kósa JP, Kocsis-Deák B, Tobiás B, Árvai K, Takács I, Podani J, Liposits Z, Lakatos P.

J Steroid Biochem Mol Biol. 2019 Apr;188:185-194. doi: 10.1016/j.jsbmb.2019.01.012. Epub 2019 Jan 24.

PMID:
30685384
4.

Germline pathogenic variants identified in women with ovarian tumors.

Carter NJ, Marshall ML, Susswein LR, Zorn KK, Hiraki S, Arvai KJ, Torene RI, McGill AK, Yackowski L, Murphy PD, Xu Z, Solomon BD, Klein RT, Hruska KS.

Gynecol Oncol. 2018 Dec;151(3):481-488. doi: 10.1016/j.ygyno.2018.09.030. Epub 2018 Oct 12.

PMID:
30322717
5.

[Literature review and presentation of our own research results regarding the effects on bone of tyrosine kinase inhibitors imatinib and nilotinib used in the treatment of oncohematological diseases].

Kirschner G, Balla B, Kósa J, Horváth P, Kövesdi A, Lakatos G, Takács I, Nagy Z, Tóbiás B, Árvai K, Lakatos P.

Orv Hetil. 2016 Sep;157(36):1429-37. doi: 10.1556/650.2016.30525. Review. Hungarian.

PMID:
27596510
6.

Effects of imatinib and nilotinib on the whole transcriptome of cultured murine osteoblasts.

Kirschner G, Balla B, Horváth P, Kövesdi A, Lakatos G, Takács I, Nagy Z, Tóbiás B, Árvai K, Kósa JP, Lakatos P.

Mol Med Rep. 2016 Sep;14(3):2025-37. doi: 10.3892/mmr.2016.5459. Epub 2016 Jun 30.

7.

Next-generation sequencing of common osteogenesis imperfecta-related genes in clinical practice.

Árvai K, Horváth P, Balla B, Tobiás B, Kató K, Kirschner G, Klujber V, Lakatos P, Kósa JP.

Sci Rep. 2016 Jun 23;6:28417. doi: 10.1038/srep28417.

8.

Clinical Use of Next-Generation Sequencing in the Diagnosis of Wilson's Disease.

Németh D, Árvai K, Horváth P, Kósa JP, Tobiás B, Balla B, Folhoffer A, Krolopp A, Lakatos PA, Szalay F.

Gastroenterol Res Pract. 2016;2016:4548039. doi: 10.1155/2016/4548039. Epub 2015 Dec 24.

9.

Genetic Alterations in Hungarian Patients with Papillary Thyroid Cancer.

Tobiás B, Halászlaki C, Balla B, Kósa JP, Árvai K, Horváth P, Takács I, Nagy Z, Horváth E, Horányi J, Járay B, Székely E, Székely T, Győri G, Putz Z, Dank M, Valkusz Z, Vasas B, Iványi B, Lakatos P.

Pathol Oncol Res. 2016 Jan;22(1):27-33. doi: 10.1007/s12253-015-9969-9. Epub 2015 Aug 11.

PMID:
26259532
10.
11.

Annotation of Sequence Variants in Cancer Samples: Processes and Pitfalls for Routine Assays in the Clinical Laboratory.

Lee LA, Arvai KJ, Jones D.

J Mol Diagn. 2015 Jul;17(4):339-51. doi: 10.1016/j.jmoldx.2015.03.003. Epub 2015 May 11. Review.

PMID:
25977238
12.

Polymorphisms of CSF1 and TM7SF4 genes in a case of mild juvenile Paget's disease found using next-generation sequencing.

Donáth J, Speer G, Kósa JP, Árvai K, Balla B, Juhász P, Lakatos P, Poór G.

Croat Med J. 2015 Apr;56(2):145-51.

13.

Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer.

Balla B, Tobiás B, Kósa JP, Podani J, Horváth P, Nagy Z, Horányi J, Járay B, Székely E, Krenács L, Árvai K, Dank M, Putz Z, Szabó B, Szili B, Valkusz Z, Vasas B, Győri G, Lakatos P, Takács I.

J Endocrinol Invest. 2015 Mar;38(3):313-21. doi: 10.1007/s40618-014-0165-7. Epub 2014 Sep 9.

PMID:
25201000
14.

Rapid and cost effective screening of breast and ovarian cancer genes using novel sequence capture method in clinical samples.

Arvai K, Horváth P, Balla B, Tőkés AM, Tobiás B, Takács I, Nagy Z, Lakatos P, Kósa JP.

Fam Cancer. 2014 Dec;13(4):583-9. doi: 10.1007/s10689-014-9730-7.

PMID:
24853695
15.

Fast and robust next-generation sequencing technique using ion torrent personal genome machine for the screening of neurofibromatosis type 1 (NF1) gene.

Balla B, Árvai K, Horváth P, Tobiás B, Takács I, Nagy Z, Dank M, Fekete G, Kósa JP, Lakatos P.

J Mol Neurosci. 2014 Jun;53(2):204-10. doi: 10.1007/s12031-014-0286-7. Epub 2014 Mar 28.

PMID:
24676943
16.

Molecular profiling of parathyroid hyperplasia, adenoma and carcinoma.

Árvai K, Nagy K, Barti-Juhász H, Peták I, Krenács T, Micsik T, Végső G, Perner F, Szende B.

Pathol Oncol Res. 2012 Jul;18(3):607-14. doi: 10.1007/s12253-011-9483-7. Epub 2011 Dec 24.

PMID:
22198862
17.

[Changes in gene expression in the course of proliferative processes in the parathyroid gland].

Szende B, Arvai K, Peták I, Nagy K, Végsô G, Perner F.

Magy Onkol. 2006;50(2):137-40. Epub 2006 Aug 4. Hungarian.

18.

[Cervical neuroblastoma in an infant].

Arvai K, Tóth J, Németh T, Kiss C, Molnár P, Oláh E.

Magy Onkol. 2004;48(1):89-95. Epub 2004 Apr 23. Hungarian.

19.

Interferon-alpha therapy in children with malignant diseases: clinical experience in twenty-four patients treated in a single pediatric oncology unit.

Kiss C, Kiss M, Szegedi I, Arvai K, Tóth J, Oláh E.

Med Pediatr Oncol. 2002 Aug;39(2):115-9. No abstract available.

PMID:
12116059
20.

Opportunistic fungal endocarditis following aortic valve replacement. A case report.

Cavallo T, Lichewitz B, Arvai K.

Rev Inst Med Trop Sao Paulo. 1968 Sep-Oct;10(5):326-30. No abstract available.

PMID:
5705661

Supplemental Content

Support Center